RF Mapanga

2.3k total citations
4 papers, 79 citations indexed

About

RF Mapanga is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, RF Mapanga has authored 4 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 1 paper in Nephrology. Recurrent topics in RF Mapanga's work include Natural Antidiabetic Agents Studies (3 papers), Natural product bioactivities and synthesis (2 papers) and Systemic Lupus Erythematosus Research (1 paper). RF Mapanga is often cited by papers focused on Natural Antidiabetic Agents Studies (3 papers), Natural product bioactivities and synthesis (2 papers) and Systemic Lupus Erythematosus Research (1 paper). RF Mapanga collaborates with scholars based in South Africa. RF Mapanga's co-authors include C. T. Musabayane, Francis O. Shode, Mark Tufts, M. Faadiel Essop and R W Milne and has published in prestigious journals such as Renal Failure.

In The Last Decade

RF Mapanga

4 papers receiving 77 citations

Peers

RF Mapanga
RF Mapanga
Citations per year, relative to RF Mapanga RF Mapanga (= 1×) peers Xingyu Wan

Countries citing papers authored by RF Mapanga

Since Specialization
Citations

This map shows the geographic impact of RF Mapanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RF Mapanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RF Mapanga more than expected).

Fields of papers citing papers by RF Mapanga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RF Mapanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RF Mapanga. The network helps show where RF Mapanga may publish in the future.

Co-authorship network of co-authors of RF Mapanga

This figure shows the co-authorship network connecting the top 25 collaborators of RF Mapanga. A scholar is included among the top collaborators of RF Mapanga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RF Mapanga. RF Mapanga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Mapanga, RF, et al.. (2014). The effects of benfotiamine in attenuating hyperglycemia-induced cardiac pathology. 2(1). 5–13. 3 indexed citations
2.
Mapanga, RF & C. T. Musabayane. (2010). The Renal Effects of Blood Glucose-Lowering Plant-Derived Extracts in Diabetes Mellitus—an Overview. Renal Failure. 32(1). 132–138. 25 indexed citations
3.
Mapanga, RF, et al.. (2009). Renal effects of plant-derived oleanolic acid in streptozotocin-induced diabetic rats. 19. 1 indexed citations
4.
Mapanga, RF, Mark Tufts, Francis O. Shode, & C. T. Musabayane. (2009). Renal Effects of Plant-Derived Oleanolic Acid in Streptozotocin-Induced Diabetic Rats. Renal Failure. 31(6). 481–491. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026